about
Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform is growing as a major contributor to overa...
Read More
83.71
2.34
(2.88%)
18.4M
XNYS Volume
XNYS 09 Jul, 2025 5:30 PM (EDT)
Acquisition
Merck to acquire Verona Pharma for $10 billion to expand its cardio-pulmonary pipeline & portfolio
See details
High Financial Strength
Affordable Valuation
Technically Neutral
Strong Performer, Under Radar
These stocks are with good quality scores and with strong financials. They are affordably priced stocks and can give good returns
View Similar
Embed DVM
Merck & Company Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..